Opportunity Information: Apply for RFA NS 23 003
The HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity (RFA-NS-23-003) created under the NIH HEAL (Helping to End Addiction Long-term) Initiative. It targets a major public health problem: more than 25 million Americans experience daily chronic pain, and for years the healthcare system leaned too heavily on opioids despite limited long-term functional benefit and a high risk of misuse and addiction. That pattern helped fuel the opioid overdose and addiction crisis, and the FOA is positioned as part of NIH's broader strategy to accelerate non-opioid, low-addiction-risk approaches to pain management.
The core purpose of the FOA is to support interdisciplinary, team-based research aimed at uncovering how pain-relieving medical devices actually work, with an emphasis on optimizing outcomes for technologies that are already FDA-approved or FDA-cleared. In other words, the program is not simply asking whether a device reduces pain; it is pushing applicants to dig into the underlying mechanisms of action, using rigorous experimental and analytical approaches that can explain why, how, for whom, and under what conditions a device produces pain relief. The expectation is that a better mechanistic understanding will translate into more effective device use in real-world settings, improved therapeutic protocols, and clearer pathways for refinement or next-generation improvements, all while reducing reliance on opioid therapies.
This opportunity uses the RM1 mechanism, which is designed to support high-impact, integrated team science. Applications are expected to be led by multiple program directors/principal investigators (PDs/PIs), reflecting the program's emphasis on collaborative synergy rather than loosely connected projects. NIH signals that funded teams should be able to accomplish goals that genuinely require close coordination across disciplines, including shared conceptual frameworks, joint experimental designs, and integrated interpretation of results. The FOA also encourages teams to develop new principles and methods for experimentation, analysis, and interpretation, suggesting a preference for projects that do more than apply standard tools and instead move the field forward in how device-based pain relief is studied and understood.
While the FOA is focused on mechanisms, it is labeled "Clinical Trial Optional," meaning applicants may propose clinical trials if they are justified by the research aims, but a clinical trial is not required. This flexibility allows teams to build a mechanistic narrative using preclinical models, human studies, computational approaches, or hybrid translational pipelines, depending on what best answers the central questions about device-mediated analgesia. The overall tone of the announcement favors ambitious objectives that can drive major advances in the science of pain relief by medical devices, rather than incremental or narrowly scoped efforts.
Eligibility is broad and includes many types of domestic organizations and governmental units. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits both with and without 501(c)(3) status (as long as they are not institutions of higher education in those specific categories); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights several categories of organizations as eligible, such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly limits non-U.S. participation: non-domestic (non-U.S.) entities and foreign institutions cannot apply as the primary applicant, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, which typically means certain discrete parts of a project can be conducted abroad when well-justified and compliant with NIH policy.
Administratively, the announcement is categorized as a discretionary grant opportunity from NIH, with an original closing date of April 27, 2023, and a creation date of August 1, 2022. It is associated with multiple CFDA listings (93.121, 93.213, 93.273, 93.279, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867), reflecting that HEAL-related pain research spans several NIH institutes and program areas. The public description does not specify an award ceiling or the expected number of awards in the provided source data, but the RM1 mechanism and the emphasis on integrated team science generally imply substantial, multi-component projects designed to produce field-shaping outputs.
In practical terms, the FOA is a call for multi-PI teams that can combine expertise such as pain neurobiology, bioengineering, neuromodulation, clinical pain medicine, computational modeling, imaging, biomarker discovery, data science, and advanced statistics to explain device-driven pain relief at a mechanistic level. The end goal is to strengthen the scientific foundations behind FDA-cleared or approved pain devices so they can be used more precisely and effectively, ultimately expanding credible non-opioid pain treatment options and helping reduce addiction-related harms tied to opioid exposure.Apply for RFA NS 23 003
- The National Institutes of Health in the education, food and nutrition, health, income security and social services sector is offering a public funding opportunity titled "HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.213, 93.273, 93.279, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867.
- This funding opportunity was created on 2022-08-01.
- Applicants must submit their applications by 2023-04-27. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity?
The HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) is a National Institutes of Health (NIH) funding opportunity announcement (FOA) under the NIH HEAL (Helping to End Addiction Long-term) Initiative. The FOA identifier provided is RFA-NS-23-003.
What problem is NIH trying to address with this FOA?
The FOA is positioned as a response to chronic pain as a major public health issue (more than 25 million Americans experience daily chronic pain) and to the historical overreliance on opioids despite limited long-term functional benefit and high risk of misuse and addiction. It is part of a broader NIH strategy to accelerate non-opioid, low-addiction-risk approaches to pain management.
What is the main purpose of the research supported by this program?
The core purpose is to support interdisciplinary, team-based research that uncovers the mechanisms of action behind pain-relieving medical devices, with an emphasis on optimizing outcomes for technologies that are already FDA-approved or FDA-cleared. The focus is on explaining why, how, for whom, and under what conditions these devices provide pain relief.
Is the program focused on proving whether a device works?
No. The emphasis is not simply on demonstrating that a device reduces pain. The program is focused on rigorous mechanistic understanding, using experimental and analytical approaches to explain how device-mediated analgesia occurs and how outcomes can be optimized.
What kinds of devices are emphasized?
The FOA emphasizes pain-relieving medical devices that are already FDA-approved or FDA-cleared, with the goal of strengthening the scientific foundation for more precise and effective use in real-world settings.
What does "mechanisms of pain relief" mean in the context of this FOA?
In this FOA, mechanistic work means going beyond outcomes alone to identify and explain the underlying processes that drive pain relief, including factors that influence variability in response (such as patient characteristics, conditions of use, and therapeutic protocols). The FOA highlights the need for approaches that can explain why and how the device produces analgesia.
What is the funding mechanism used for this opportunity?
This opportunity uses the NIH RM1 mechanism, which is designed to support high-impact, integrated team science.
Does the FOA expect a multi-PI leadership structure?
Yes. Applications are expected to be led by multiple program directors/principal investigators (PDs/PIs), reflecting an emphasis on collaborative synergy and integrated team science rather than loosely connected projects.
What does NIH mean by "integrated team science" here?
The FOA signals that funded teams should pursue goals that genuinely require close coordination across disciplines, including shared conceptual frameworks, joint experimental designs, and integrated interpretation of results.
Are clinical trials required?
No. The FOA is labeled "Clinical Trial Optional," meaning clinical trials may be proposed if justified by the research aims, but they are not required.
If clinical trials are optional, what other study approaches could fit?
Based on the description, teams may build mechanistic evidence using preclinical models, human studies, computational approaches, or hybrid translational pipelines, depending on what best answers the central questions about device-mediated pain relief.
What types of projects does the FOA appear to favor?
The overall tone favors ambitious, field-advancing objectives that can drive major advances in the science of pain relief by medical devices, rather than incremental or narrowly scoped efforts.
Does the FOA encourage new methods or just applying existing tools?
The FOA encourages teams to develop new principles and methods for experimentation, analysis, and interpretation, suggesting a preference for work that advances how device-based pain relief is studied and understood.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations and governmental units. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (with the noted limitation in the provided description); for-profit organizations other than small businesses; and small businesses.
Are minority-serving institutions and community-based organizations eligible?
Yes. The FOA explicitly highlights categories such as Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, and regional organizations as eligible.
Are U.S. territories eligible?
Yes. U.S. territories or possessions are explicitly mentioned as eligible in the provided description.
Can foreign institutions apply as the primary applicant?
No. The FOA states that non-domestic (non-U.S.) entities and foreign institutions cannot apply as the primary applicant.
Can a non-U.S. component of a U.S. organization apply?
No. The description states that non-domestic components of U.S. organizations are not eligible to apply.
Are any foreign activities allowed at all?
Yes. The FOA indicates that foreign components (as defined in the NIH Grants Policy Statement) are allowed. This typically means discrete parts of a project can be conducted abroad when well-justified and compliant with NIH policy.
When was this FOA created and when did it close (based on the provided information)?
The creation date provided is August 1, 2022. The original closing date provided is April 27, 2023.
Which agency is offering this opportunity?
The opportunity is offered by the National Institutes of Health (NIH).
How is this grant opportunity categorized?
The announcement is described as a discretionary grant opportunity from NIH.
What is the HEAL Initiative and how does it relate to this FOA?
The NIH HEAL (Helping to End Addiction Long-term) Initiative is described as NIH's effort to accelerate solutions to the opioid crisis and improve pain management. This FOA fits within that strategy by aiming to expand credible non-opioid pain treatment options through mechanistic understanding and optimization of pain-relieving medical devices.
What kinds of expertise might a competitive team include?
The description suggests teams may combine expertise such as pain neurobiology, bioengineering, neuromodulation, clinical pain medicine, computational modeling, imaging, biomarker discovery, data science, advanced statistics, and related fields needed to explain device-driven pain relief at a mechanistic level.
What outcomes does NIH seem to want from the funded work?
The FOA frames expected value in terms of improved mechanistic understanding that can translate into more effective real-world device use, improved therapeutic protocols, and clearer pathways for refinement or next-generation improvements, while reducing reliance on opioid therapies.
Does the provided information include an award ceiling or the expected number of awards?
No. The provided description states that the public source data does not specify an award ceiling or the expected number of awards.
Are there identifiers or listings associated with this opportunity?
Yes. The FOA identifier given is RFA-NS-23-003, and it is associated with multiple CFDA listings: 93.121, 93.213, 93.273, 93.279, 93.393, 93.846, 93.847, 93.853, 93.865, 93.866, and 93.867.
Why does the FOA mention multiple CFDA listings?
The provided description indicates that HEAL-related pain research spans several NIH institutes and program areas, which is reflected by multiple CFDA listings.
How does this FOA connect device research to opioid harm reduction?
The FOA is framed around strengthening non-opioid pain management by improving the mechanistic understanding and optimization of FDA-cleared or approved pain devices, with the broader intent of reducing reliance on opioids and lowering addiction-related harms tied to opioid exposure.
Browse more opportunities from the same category: Education, Food and Nutrition, Health, Income Security and Social Services
Next opportunity: P23AS00041 National Park Service Chesapeake Gateways Grants
Previous opportunity: Award Competition for Hollings Manufacturing Extension Partnership (MEP) Centers in the States of Arizona and Maryland with District of Columbia
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA NS 23 003
Applicants also applied for:
Applicants who have applied for this opportunity (RFA NS 23 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed) Apply for RFA NS 22 070 Funding Number: RFA NS 22 070 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $750,000 |
| Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) Apply for PAR 23 024 Funding Number: PAR 23 024 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $350,000 |
| Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32) Apply for RFA OD 22 027 Funding Number: RFA OD 22 027 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Independent Clinical Trial Not Allowed) Apply for RFA OD 23 003 Funding Number: RFA OD 23 003 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $200,000 |
| Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed) Apply for RFA PM 23 001 Funding Number: RFA PM 23 001 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Small Grants to Enhance the Use of the All of Us Research Programs Data (R03 Clinical Trial Not Allowed) Apply for RFA PM 23 002 Funding Number: RFA PM 23 002 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) Apply for PAR 23 137 Funding Number: PAR 23 137 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $250,000 |
| Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) Apply for RFA TR 23 011 Funding Number: RFA TR 23 011 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $1,500,000 |
| HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) Apply for RFA NS 23 028 Funding Number: RFA NS 23 028 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $1,500,000 |
| HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain: Acute Pain Clinical Trials Program (U01 Clinical Trial Required) Apply for RFA HD 24 011 Funding Number: RFA HD 24 011 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) Apply for RFA NS 24 019 Funding Number: RFA NS 24 019 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Apply for PAR 24 075 Funding Number: PAR 24 075 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) Apply for PAR 24 076 Funding Number: PAR 24 076 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 25 012 Funding Number: RFA NS 25 012 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $350,000 |
| Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional) Apply for RFA MH 25 185 Funding Number: RFA MH 25 185 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required) Apply for PAR 24 217 Funding Number: PAR 24 217 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| Time-Sensitive Obesity Policy and Program Evaluation (R01) Apply for PAR 15 346 Funding Number: PAR 15 346 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) Apply for RFA NS 25 023 Funding Number: RFA NS 25 023 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: $350,000 |
| Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01-Clinical Trial Not Allowed) Apply for PAR 25 312 Funding Number: PAR 25 312 Agency: National Institutes of Health Category: Education, Food and Nutrition, Health, Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 23 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.